An unusual case of subclinical diffuse glucagonoma coexisting with two nodules in the pancreas: Characteristic features on computed tomography

被引:8
作者
Azemoto, N. [2 ]
Kumagi, T. [1 ]
Yokota, T. [3 ]
Kuroda, T. [1 ]
Koizumi, M. [1 ]
Yamanishi, H. [1 ]
Soga, Y. [4 ]
Furukawa, S. [1 ]
Abe, M. [1 ]
Ikeda, Y. [2 ]
Hiasa, Y. [1 ]
Matsuura, B. [1 ]
Watanabe, J.
Kushihata, F.
Onji, M. [1 ]
机构
[1] Ehime Univ, Grad Sch Med, Dept Gastroenterol & Metabol, Toon, Ehime, Japan
[2] Ehime Univ Hosp, Endoscopy Ctr, Toon, Ehime, Japan
[3] Matsuyama Red Cross Hosp, Ctr Liver Biliary Pancreat Dis, Matsuyama, Ehime, Japan
[4] Ehime Univ Hosp, Div Pathol, Toon, Ehime, Japan
关键词
ENDOCRINE TUMORS; NESIDIOBLASTOSIS; HYPERPLASIA;
D O I
10.1016/j.clinre.2011.12.003
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
A lesion was discovered in the tail of the pancreas by ultrasonography performed during a health checkup for a 59-year-old Japanese man. Abdominal contrast-enhanced computed tomography (CE-CT) revealed strong enhancement in a 4-cm tumor in the pancreatic tail and in a 1-cm tumor in the pancreatic body. Serum glucagon levels were elevated to 54,405 pg/mL and a preoperative diagnosis of glucagonoma was made. The pancreatic tail and spleen were resected en bloc, along with a protruding tumor in the pancreatic body. However, histopathological evaluation revealed diffuse glucagonoma throughout the pancreas. When we retrospectively reviewed abdominal CE-CT after the operation, the entire pancreas was seen to be enlarged and diffusely enhanced by strong spots. Immunohistochemical examination using anti-CD31 demonstrated rich microvessels in two solid glucagonomas as well as microglucagonoma throughout the entire pancreas, indicating hypervascularity. Enlarged pancreas and diffuse enhancement of the pancreas by strong spots may be characteristic features of diffuse glucagonoma on abdominal CE-CT. (C) 2011 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:E43 / E47
页数:5
相关论文
共 14 条
[1]  
[Anonymous], 2004, WHO CLASSIFICATION T
[2]   Cutaneous manifestations of internal malignant tumors [J].
Becker, SW ;
Kahn, D ;
Rothman, S .
ARCHIVES OF DERMATOLOGY AND SYPHILOLOGY, 1942, 45 (06) :1069-1080
[3]  
Chen HW, 2005, J FORMOS MED ASSOC, V104, P363
[4]   Preliminary results of a Japanese nationwide survey of neuroendocrine gastrointestinal tumors [J].
Ito, Tetsuhide ;
Tanaka, Masao ;
Sasano, Hironobu ;
Osamura, Yoshiyuki R. ;
Sasaki, Iwao ;
Kimura, Wataru ;
Takano, Koji ;
Obara, Takao ;
Ishibashi, Miyuki ;
Nakao, Kazuwa ;
Doi, Ryuichiro ;
Shimatsu, Akira ;
Nishida, Toshirou ;
Komoto, Izumi ;
Hirata, Yukio ;
Imamura, Masayuki ;
Kawabe, Ken ;
Nakamura, Kazuhiko .
JOURNAL OF GASTROENTEROLOGY, 2007, 42 (06) :497-500
[5]   Endocrine pancreatic tumors with glucagon hypersecretion:: a retrospective study of 23 cases during 20 years [J].
Kindmark, Henrik ;
Sundin, Anders ;
Granberg, Dan ;
Dunder, Kristina ;
Skogseid, Britt ;
Janson, Eva Tiensuu ;
Welin, Staffan ;
Oberg, Kjell ;
Eriksson, Barbro .
MEDICAL ONCOLOGY, 2007, 24 (03) :330-337
[6]  
MALLINSON CN, 1974, LANCET, V2, P1
[7]   Pancreatic endocrine tumors [J].
Mansour, JC ;
Chen, H .
JOURNAL OF SURGICAL RESEARCH, 2004, 120 (01) :139-161
[8]   Nesidioblastosis with glucagon-reactive islet cell hyperplasia: A case report [J].
Martignoni, ME ;
Kated, H ;
Stiegler, M ;
Buchler, MW ;
Friess, H ;
Zimmermann, A ;
Schirp, U ;
Nitzsche, EU .
PANCREAS, 2003, 26 (04) :402-405
[9]   PLASMA IMMUNOREACTIVE GLUCAGON FRACTIONS IN 4 CASES OF GLUCAGONOMA - INCREASED LARGE GLUCAGON - IMMUNOREACTIVITY [J].
RECANT, L ;
PERRINO, PV ;
BHATHENA, SJ ;
DANFORTH, DN ;
LAVINE, RL .
DIABETOLOGIA, 1976, 12 (04) :319-326
[10]   Helical CT of pancreatic endocrine tumors [J].
Rodallec, M ;
Vilgrain, V ;
Zins, M ;
Couvelard, A ;
Ruszniewski, P ;
Menu, Y .
JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY, 2002, 26 (05) :728-733